Literature DB >> 21688193

Untreated hypertension decreases heritability of cognition in late middle age.

Terrie Vasilopoulos1, William S Kremen, Kathleen Kim, Matthew S Panizzon, Phyllis K Stein, Hong Xian, Michael D Grant, Michael J Lyons, Rosemary Toomey, Lindon J Eaves, Carol E Franz, Kristen C Jacobson.   

Abstract

Hypertension is a risk factor for cognitive decline, but the mechanisms underlying the effects of hypertension on cognition, particularly in midlife, are unclear. We examined whether hypertension modifies genetic influences on individual differences in cognition. Nine cognitive domains and general cognitive ability were assessed in a sample of 1,237 male twins aged 51-60 who were divided into three blood pressure groups: non-hypertensive; medicated hypertensive; and unmedicated hypertensive. Heritability was significantly lower among unmedicated hypertensives compared to medicated hypertensives and non-hypertensives for visual-spatial ability (p = 0.013) and episodic memory (p = 0.004). There were no heritability differences between non-hypertensives and medicated hypertensives. In addition, there were no significant differences in mean level cognition across the three blood pressure groups. These results suggest that in middle-aged men, untreated hypertension suppresses normal genetic influences on individual differences in certain domains of cognition prior to the emergence of hypertension-related effects on cognitive performance. These results further suggest that antihypertensive medication may protect against or reverse this effect.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21688193      PMCID: PMC3227796          DOI: 10.1007/s10519-011-9479-9

Source DB:  PubMed          Journal:  Behav Genet        ISSN: 0001-8244            Impact factor:   2.805


  46 in total

1.  Testosterone modifies the effect of APOE genotype on hippocampal volume in middle-aged men.

Authors:  M S Panizzon; R Hauger; A M Dale; L J Eaves; L T Eyler; B Fischl; C Fennema-Notestine; C E Franz; M D Grant; A J Jak; K C Jacobson; M J Lyons; S P Mendoza; M C Neale; E C Prom-Wormley; L J Seidman; M T Tsuang; H Xian; W S Kremen
Journal:  Neurology       Date:  2010-09-07       Impact factor: 9.910

2.  Aging and Executive Control: Reports of a Demise Greatly Exaggerated.

Authors:  Paul Verhaeghen
Journal:  Curr Dir Psychol Sci       Date:  2011-06

3.  The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons.

Authors:  M N Haan; L Shemanski; W J Jagust; T A Manolio; L Kuller
Journal:  JAMA       Date:  1999-07-07       Impact factor: 56.272

4.  Heritability of word recognition in middle-aged men varies as a function of parental education.

Authors:  William S Kremen; Kristen C Jacobson; Hong Xian; Seth A Eisen; Brian Waterman; Rosemary Toomey; Michael C Neale; Ming T Tsuang; Michael J Lyons
Journal:  Behav Genet       Date:  2005-07       Impact factor: 2.805

5.  Does parental education have a moderating effect on the genetic and environmental influences of general cognitive ability in early adulthood?

Authors:  Michael D Grant; William S Kremen; Kristen C Jacobson; Carol Franz; Hong Xian; Seth A Eisen; Rosemary Toomey; Ruth E Murray; Michael J Lyons
Journal:  Behav Genet       Date:  2010-03-19       Impact factor: 2.805

6.  Effects of six anti-hypertensive medications on cognitive performance.

Authors:  Matthew F Muldoon; Shari R Waldstein; Christopher M Ryan; John Richard Jennings; Joanna M Polefrone; Alvin P Shapiro; Stephen B Manuck
Journal:  J Hypertens       Date:  2002-08       Impact factor: 4.844

7.  Association of higher diastolic blood pressure levels with cognitive impairment.

Authors:  G Tsivgoulis; A V Alexandrov; V G Wadley; F W Unverzagt; R C P Go; C S Moy; B Kissela; G Howard
Journal:  Neurology       Date:  2009-08-25       Impact factor: 9.910

8.  Are patients reliable when self-reporting medication use? Validation of structured drug interviews and home visits by drug analysis and prescription data in acutely hospitalized patients.

Authors:  Bente Glintborg; Peter René Hillestrøm; Lenette Holm Olsen; Kim Peder Dalhoff; Henrik Enghusen Poulsen
Journal:  J Clin Pharmacol       Date:  2007-11       Impact factor: 3.126

Review 9.  Exercise: a behavioral intervention to enhance brain health and plasticity.

Authors:  Carl W Cotman; Nicole C Berchtold
Journal:  Trends Neurosci       Date:  2002-06       Impact factor: 13.837

10.  High blood pressure was associated with cognitive function in middle-age in the Whitehall II study.

Authors:  Archana Singh-Manoux; Michael Marmot
Journal:  J Clin Epidemiol       Date:  2005-12       Impact factor: 6.437

View more
  4 in total

1.  Genetic influences on hippocampal volume differ as a function of testosterone level in middle-aged men.

Authors:  Matthew S Panizzon; Richard L Hauger; Lindon J Eaves; Chi-Hua Chen; Anders M Dale; Lisa T Eyler; Bruce Fischl; Christine Fennema-Notestine; Carol E Franz; Michael D Grant; Kristen C Jacobson; Amy J Jak; Michael J Lyons; Sally P Mendoza; Michael C Neale; Elizabeth Prom-Wormley; Larry J Seidman; Ming T Tsuang; Hong Xian; William S Kremen
Journal:  Neuroimage       Date:  2011-10-01       Impact factor: 6.556

2.  Effects of hypertension and diabetes on sentence comprehension in aging.

Authors:  Dalia Cahana-Amitay; Martin L Albert; Emmanuel A Ojo; Jesse Sayers; Mira Goral; Loraine K Obler; Avron Spiro
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2012-10-09       Impact factor: 4.077

3.  Erectile dysfunction, vascular risk, and cognitive performance in late middle age.

Authors:  Caitlin S Moore; Michael D Grant; Tyler A Zink; Matthew S Panizzon; Carol E Franz; Mark W Logue; Richard L Hauger; William S Kremen; Michael J Lyons
Journal:  Psychol Aging       Date:  2014-03

4.  Association between hypertension and cognitive function: A cross-sectional study in people over 45 years old in China.

Authors:  Jiate Wei; Xin Yin; Qi Liu; Libo Tan; Chongqi Jia
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-09-26       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.